Paper2494640
Long-term tobramycin aerosol therapy in cystic fibrosis.
Steinkamp G and 6 others. Pediatr Pulmonol, 1989. Cited by 123 papers, by iCite.
Cite this record
ConductScience Library. Long-term tobramycin aerosol therapy in cystic fibrosis. Papers, record 2494640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2494640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Pseudomonas Infections | Major topic |
| Respiratory Tract Infections | Major topic |
| Tobramycin | Major topic |
| Administration, Inhalation | |
| Adolescent | |
| Aerosols | |
| Child | |
| Drug Resistance, Microbial | |
| Humans | |
| Pseudomonas aeruginosa | |
| Time Factors |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36373968 | Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36373968 | PubMed |
| 33255354 | Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases. | J Clin Med | 2020 | https://conductscience.org/library/papers/33255354 | PubMed |
| 31112621 | Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/31112621 | PubMed |
| 29904366 | Bilateral Vestibular Weakness. | Front Neurol | 2018 | https://conductscience.org/library/papers/29904366 | PubMed |
| 29607494 | Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29607494 | PubMed |
| 26959239 | Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients. | PLoS One | 2016 | https://conductscience.org/library/papers/26959239 | PubMed |
| 26573178 | Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin. | Future Microbiol | 2015 | https://conductscience.org/library/papers/26573178 | PubMed |
| 21233507 | Clinical significance of microbial infection and adaptation in cystic fibrosis. | Clin Microbiol Rev | 2011 | https://conductscience.org/library/papers/21233507 | PubMed |
| 20692633 | Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis. | Paediatr Respir Rev | 2010 | https://conductscience.org/library/papers/20692633 | PubMed |
| 20191398 | Inhaled anti-infective agents: emphasis on colistin. | Infection | 2010 | https://conductscience.org/library/papers/20191398 | PubMed |
| 19538104 | Inhaled therapeutics for prevention and treatment of pneumonia. | Expert Opin Drug Saf | 2009 | https://conductscience.org/library/papers/19538104 | PubMed |
| 14609360 | Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. | Drugs | 2003 | https://conductscience.org/library/papers/14609360 | PubMed |
| 12096202 | Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. | Thorax | 2002 | https://conductscience.org/library/papers/12096202 | PubMed |
| 12083973 | Nebulized antibiotics in cystic fibrosis. | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/12083973 | PubMed |
| 11706924 | Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics. | Paediatr Drugs | 2001 | https://conductscience.org/library/papers/11706924 | PubMed |
| 11598071 | Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein. | Infect Immun | 2001 | https://conductscience.org/library/papers/11598071 | PubMed |
| 10319054 | Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. | Thorax | 1998 | https://conductscience.org/library/papers/10319054 | PubMed |
| 10086932 | Is prolonged rotavirus infection a common cause of protracted diarrhoea? | Arch Dis Child | 1999 | https://conductscience.org/library/papers/10086932 | PubMed |
| 10086931 | Evidence for using nebulised antibiotics in cystic fibrosis. | Arch Dis Child | 1999 | https://conductscience.org/library/papers/10086931 | PubMed |
| 9713010 | Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation. | Arch Dis Child | 1998 | https://conductscience.org/library/papers/9713010 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2494640
GET https://conductscience.org/api/papers/v1/2494640/cited_by?page=2